The second most common type of cancer that urologists treat is bladder
cancer, therefore, the best treatment strategies for each patient depend on
early detection, accurate staging, and diagnosis. Also, its detection methods
should be developed and studied frequently to be improved. This study
aimed to assess the utility of contrast-enhanced ultrasound in Bladder cancer
diagnosis, particularly in differentiating low-grade from high-grade bladder
cancer. The Cochrane Library, EMBASE, and PubMed were used to search the
literature until 2022. The criteria for inclusion were studies with patients
suspected or unknown bladder cancer undergo contrast-enhanced ultrasound
for preoperative diagnosis and local staging based on cystoscopy or
transurethral resection. After removal of duplication, abstract and title
screening, the review included five studies. Information regarding author
name, year of publication, objective, study participant’s characteristics,
findings and conclusion were all extracted from the studies. With a mean age
ranging from 60 to 68 years, the included publications featured a total of 436
bladder cancer patients. Upon contrast-enhanced ultrasound, 222 bladder
cancer lesions were found to be positive, whereas 214 lesions were found to
be negative; histology revealed 78 cases of muscle invasive, 118 cases of nonmuscle
invasive bladder cancers, 144 cases of high-grade bladder cancer, and
96 cases of low-grade bladder cancer. According to the results of our
systematic review, contrast-enhanced ultrasound has a good level of
diagnostic accuracy, sensitivity, and specificity.
Keywords: Bladder cancer, ultrasound, diagnosis
